文献速递儿童内分泌与遗传代谢

美国儿童青少年糖尿病前期与糖尿病的筛查与诊断

Screening and Diagnosis of Prediabetes and Diabetes in US Children and Adolescents.
PubMed 文献 · Pediatrics · 2020-08-10

结果显示25.5%的美国青少年符合筛查条件,但筛查标准对高血糖检测的敏感性和特异性均较低,确诊的未诊断糖尿病罕见(<0.5%),大多数糖尿病已被诊断;HbA1c定义的高血糖与心脏代谢风险的关联更强且更特异。结论认为无论筛查资格如何,HbA1c是一种特异且有用的非空腹检测,可识别可从生活方式干预中获益的高危青少年。

要点

  • 25.5%的美国青少年符合糖尿病筛查条件,但筛查标准敏感性低。
  • 确诊的未诊断糖尿病罕见(<0.5%),大多数糖尿病已被诊断。
  • HbA1c定义的高血糖与心脏代谢风险关联更强且更特异。

核心结论

  • 四分之一美国青少年符合筛查条件,但检测阳性者少,尤其糖尿病。
  • 大多数美国青少年糖尿病病例已被诊断。
  • HbA1c是特异且有用的非空腹检测,可识别高危青少年。

研究设计与样本

  • 评估美国糖尿病协会基于风险的筛查标准性能。
  • 评估基于HbA1c、FPG或其组合的糖尿病前期和糖尿病临床定义识别高心脏代谢风险青少年的性能。

主要发现

  • 筛查标准检测任何高血糖的敏感性低:HbA1c≥5.7%敏感性55.5%、特异性76.3%;FPG≥100 mg/dL敏感性35.8%、特异性77.1%。
  • 确诊的未诊断糖尿病(HbA1c≥6.5%且FPG≥126 mg/dL)罕见,<0.5%的青少年。
  • 大多数(>85%)糖尿病病例被诊断。
  • HbA1c定义的高血糖与心脏代谢风险的关联更强且更特异(特异性98.6%;敏感性4.0%)优于FPG定义的高血糖(特异性90.1%;敏感性19.4%)。

关键数值与推荐

  • HbA1c≥5.7%检测任何高血糖:敏感性55.5%,特异性76.3%。
  • FPG≥100 mg/dL检测任何高血糖:敏感性35.8%,特异性77.1%。
  • 确诊的未诊断糖尿病定义:HbA1c≥6.5%且FPG≥126 mg/dL,患病率<0.5%。
  • HbA1c定义的高血糖:特异性98.6%,敏感性4.0%。
  • FPG定义的高血糖:特异性90.1%,敏感性19.4%。

临床怎么用

  • 无论筛查资格如何,可考虑使用HbA1c作为非空腹检测识别高危青少年。
  • HbA1c定义的高血糖对识别心脏代谢高风险青少年更具特异性。
  • 符合筛查条件的青少年中检测阳性率低,需注意筛查标准的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal approach to screening and diagnosis of prediabetes and diabetes in youth is uncertain. METHODS: We conducted a cross-sectional analysis of 14 119 youth aged 10 to 19 years in the 1999-2016 NHANES. First, we examined the performance of American Diabetes Association risk-based screening criteria. Second, we evaluated the performance of current clinical definitions of prediabetes and diabetes based on hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), either HbA1c or FPG, or both HbA1c and FPG (confirmatory definition) to identify youth at high cardiometabolic risk. RESULTS: Overall, 25.5% of US youth (10.6 million in 2016) were eligible for screening. Sensitivity and specificity of the screening criteria for detecting any hyperglycemia were low for both HbA1c ≥5.7% (sensitivity = 55.5%, specificity = 76.3%) and FPG ≥100 mg/dL (sensitivity = 35.8%, specificity = 77.1%). Confirmed undiagnosed diabetes (HbA1c ≥6.5% and FPG ≥126 mg/dL) was rare, <0.5% of youth. Most (>85%) cases of diabetes were diagnosed. Associations with cardiometabolic risk were consistently stronger and more specific for HbA1c-defined hyperglycemia (specificity = 98.6%; sensitivity = 4.0%) than FPG-defined hyperglycemia (specificity = 90.1%; sensitivity = 19.4%). CONCLUSIONS: One-quarter of US youth are eligible for screening for diabetes and prediabetes; however, few will test positive, especially for diabetes. Most cases of diabetes in US youth are diagnosed. Regardless of screening eligibility, we found that HbA1c is a specific and useful nonfasting test to identify high-risk youth who could benefit from lifestyle interventions to prevent diabetes and cardiovascular risk in adulthood.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Wallace AS, Wang D, Shin JI, et al. Screening and Diagnosis of Prediabetes and Diabetes in US Children and Adolescents. Pediatrics. 2020. PMID: 32778539. doi:10.1542/peds.2020-0265

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。